EGFR and lung cancer: If cytological specimens such as bronchial wash specimens could replace lung biopsy specimens when analyzing EGFR mutation status in patients with inoperable lung cancer, it would be a powerful option, as repeated lung biopsy could be avoided in patients with poor clinical condition.